ATE133407T1 - Neue arylalkanoylaminderivate und diese enthaltendes arzneimittel - Google Patents
Neue arylalkanoylaminderivate und diese enthaltendes arzneimittelInfo
- Publication number
- ATE133407T1 ATE133407T1 AT91910447T AT91910447T ATE133407T1 AT E133407 T1 ATE133407 T1 AT E133407T1 AT 91910447 T AT91910447 T AT 91910447T AT 91910447 T AT91910447 T AT 91910447T AT E133407 T1 ATE133407 T1 AT E133407T1
- Authority
- AT
- Austria
- Prior art keywords
- alkanoylamine
- derivatives
- products containing
- containing same
- medicinal products
- Prior art date
Links
- 229940126601 medicinal product Drugs 0.000 title 1
- -1 1,2,3,4-tetrahydronaphthalenyl Chemical group 0.000 abstract 3
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Chemical group C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 abstract 2
- 230000002490 cerebral effect Effects 0.000 abstract 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 2
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 abstract 2
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 abstract 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 2
- 208000000044 Amnesia Diseases 0.000 abstract 1
- 208000031091 Amnestic disease Diseases 0.000 abstract 1
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 102000056251 Prolyl Oligopeptidases Human genes 0.000 abstract 1
- 101710178372 Prolyl endopeptidase Proteins 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000006986 amnesia Effects 0.000 abstract 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000007954 hypoxia Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 150000002825 nitriles Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14728190 | 1990-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE133407T1 true ATE133407T1 (de) | 1996-02-15 |
Family
ID=15426662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91910447T ATE133407T1 (de) | 1990-06-07 | 1991-06-07 | Neue arylalkanoylaminderivate und diese enthaltendes arzneimittel |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5407950A (de) |
| EP (1) | EP0536399B1 (de) |
| AT (1) | ATE133407T1 (de) |
| AU (1) | AU643300B2 (de) |
| CA (1) | CA2084204A1 (de) |
| DE (1) | DE69116692T2 (de) |
| DK (1) | DK0536399T3 (de) |
| WO (1) | WO1991018877A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0670309A1 (de) * | 1992-11-20 | 1995-09-06 | Japan Tobacco Inc. | Verbindung mit prolye-endopeptidase inhibierender aktivität und ihre pharmazeutische verwendung |
| JP3810097B2 (ja) * | 1993-01-15 | 2006-08-16 | 明治製菓株式会社 | ピロリジン−2−イルカルボニル複素環式化合物誘導体 |
| EP1161415B1 (de) | 1999-03-15 | 2005-07-13 | Axys Pharmaceuticals, Inc. | N-cyanomethylamide als protease inhibitoren |
| IL156577A0 (en) | 2000-12-22 | 2004-01-04 | Axys Pharm Inc | Selective cathepsin s inhibitors and pharmaceutical compositions containing the same |
| US7030116B2 (en) | 2000-12-22 | 2006-04-18 | Aventis Pharmaceuticals Inc. | Compounds and compositions as cathepsin inhibitors |
| WO2003024924A1 (en) | 2001-09-14 | 2003-03-27 | Aventis Pharmaceuticals Inc. | Novel compounds and compositions as cathepsin inhibitors |
| RU2004117877A (ru) | 2001-11-14 | 2006-01-10 | Авентис Фармасьютикалз Инк. (Us) | Олигопептиды и композиции, содержащие их, в качестве ингибиторов катепсина s |
| FI20030014A0 (fi) * | 2003-01-03 | 2003-01-03 | Orion Corp | Prolyylioligopeptidaasia inhiboivaa aktiivisuutta omaavia yhdisteitä |
| ATE462432T1 (de) | 2003-05-05 | 2010-04-15 | Probiodrug Ag | Glutaminylcyclase-hemmer |
| JP2007509898A (ja) | 2003-11-03 | 2007-04-19 | プロビオドルグ エージー | 神経障害治療に有用な組合せ |
| KR101099206B1 (ko) | 2004-02-05 | 2011-12-27 | 프로비오드룩 아게 | 신규한 글루타미닐 시클라제 저해제 |
| EP1888562B1 (de) * | 2005-04-22 | 2014-06-18 | Alantos Pharmaceuticals Holding, Inc. | Dipeptidylpeptidase-iv-hemmer |
| EP1760076A1 (de) | 2005-09-02 | 2007-03-07 | Ferring B.V. | FAP Inhibitoren |
| JP5379692B2 (ja) | 2006-11-09 | 2013-12-25 | プロビオドルグ エージー | 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての3−ヒドロキシ−1,5−ジヒドロ−ピロール−2−オン誘導体 |
| EP2091948B1 (de) | 2006-11-30 | 2012-04-18 | Probiodrug AG | Neue inhibitoren von glutaminylcyclase |
| CA2679446C (en) | 2007-03-01 | 2016-05-17 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
| US9656991B2 (en) | 2007-04-18 | 2017-05-23 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| US8524654B2 (en) * | 2007-05-21 | 2013-09-03 | The Uab Research Foundation | Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation |
| BR112012008346B1 (pt) | 2009-09-11 | 2021-12-21 | Vivoryon Therapeutics N.V. | Derivados heterocíclicos, seu processo de preparação, e composição farmacêutica |
| WO2011107530A2 (en) | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Novel inhibitors |
| DK2545047T3 (da) | 2010-03-10 | 2014-07-28 | Probiodrug Ag | Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5) |
| EP2560953B1 (de) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Hemmer der glutaminylzyklase |
| WO2012123563A1 (en) | 2011-03-16 | 2012-09-20 | Probiodrug Ag | Benz imidazole derivatives as inhibitors of glutaminyl cyclase |
| DE102016116130A1 (de) * | 2016-08-30 | 2018-03-01 | Universität Bielefeld | Verfahren zur Herstellung chiraler Aminonitrile |
| PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3680578D1 (de) * | 1985-04-16 | 1991-09-05 | Suntory Ltd | Dipeptid-derivate, verfahren zur herstellung, pharmazeutische zusammensetzungen und ihre anwendung. |
| JP2526084B2 (ja) * | 1987-02-23 | 1996-08-21 | 小野薬品工業株式会社 | 新規なチアゾリジン誘導体 |
| DE3712364A1 (de) * | 1987-04-11 | 1988-10-27 | Hoechst Ag | Neue pyrrolidin-2-(1,3-dicarbonyl)-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung |
| US4857524A (en) * | 1987-08-08 | 1989-08-15 | Kissei Pharmaceutical Co., Ltd. | Thiazolidine compounds and therapeutic method |
| JPH0670023B2 (ja) * | 1987-08-08 | 1994-09-07 | キッセイ薬品工業株式会社 | チアゾリジン誘導体 |
| JPH01250370A (ja) * | 1987-12-23 | 1989-10-05 | Zeria Pharmaceut Co Ltd | 新規アミノ酸イミド誘導体、製法ならびに用途 |
| US5053414A (en) * | 1988-04-08 | 1991-10-01 | Ono Pharmaceutical Co., Ltd. | Heterocyclic compounds |
| US5212191A (en) * | 1988-04-08 | 1993-05-18 | Ono Pharmaceutical Co., Ltd. | Heterocyclic compounds |
| CA2004028C (en) * | 1988-12-08 | 1998-09-22 | Motoki Torizuka | Condensed benzene derivative |
| WO1990012005A1 (fr) * | 1989-04-13 | 1990-10-18 | Japan Tobacco Inc. | Nouveaux derives aminoacides possedant une activite d'inhibiteur de la prolylendopeptidase |
-
1991
- 1991-06-07 CA CA002084204A patent/CA2084204A1/en not_active Abandoned
- 1991-06-07 US US07/952,499 patent/US5407950A/en not_active Expired - Fee Related
- 1991-06-07 DK DK91910447.1T patent/DK0536399T3/da active
- 1991-06-07 DE DE69116692T patent/DE69116692T2/de not_active Expired - Fee Related
- 1991-06-07 AT AT91910447T patent/ATE133407T1/de not_active IP Right Cessation
- 1991-06-07 WO PCT/JP1991/000771 patent/WO1991018877A1/ja not_active Ceased
- 1991-06-07 AU AU79866/91A patent/AU643300B2/en not_active Ceased
- 1991-06-07 EP EP91910447A patent/EP0536399B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU643300B2 (en) | 1993-11-11 |
| DK0536399T3 (da) | 1996-06-03 |
| CA2084204A1 (en) | 1991-12-08 |
| DE69116692D1 (de) | 1996-03-07 |
| DE69116692T2 (de) | 1996-09-05 |
| US5407950A (en) | 1995-04-18 |
| AU7986691A (en) | 1991-12-31 |
| WO1991018877A1 (en) | 1991-12-12 |
| EP0536399B1 (de) | 1996-01-24 |
| EP0536399A1 (de) | 1993-04-14 |
| EP0536399A4 (en) | 1993-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE133407T1 (de) | Neue arylalkanoylaminderivate und diese enthaltendes arzneimittel | |
| ES2077138T3 (es) | Derivados de aminocumarano, su produccion y su uso. | |
| DE60140708D1 (de) | Prolinderivative und deren Verwendung als Medikamente | |
| DK131893A (da) | 2-(Substitueret methyl)-4-(substitueret ethoxy)-5-(lavere alkyl)-pyridinforbindelser, farmaceutisk præparat, som indeholder sådanne samt anvendelse af en sådan forbindelse til fremstilling af et farmaceutisk præparat | |
| EP0495776A4 (de) | Stabilisierte komplexe bestehend aus stickoxyd/primäre amine zur verwendung als kardiovaskuläre wirkstoffe. | |
| ATE181553T1 (de) | Kondensierte thiazolverbindungen, ihre darstellung und ihre anwendung | |
| HUT45983A (en) | Process for production of derivatives of imidazolidinone | |
| EP0191867A4 (de) | Tricyclische oder tetracyclische verbindungen, deren herstellung und arzneimittel die diese enthalten. | |
| TW347389B (en) | Taxoids, their preparation and pharmaceutical compositions containing them | |
| HUT64318A (en) | Process for production benzodpyrane derivativs and pharmaceutical preparations containing these compounds as effective substance | |
| DE69837334D1 (de) | Heterozyclische verbindungen, ihr herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen | |
| EP0318029A3 (en) | Cyclic amine and pharmacological composition | |
| ATE171704T1 (de) | Optisch wirksame alkylendioxybenzolderivate und ihre verwendung als arzneimittel | |
| ATE100102T1 (de) | Substituierte derivate von 20,21dinoreburnamenin, verfahren zur herstellung und so hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen. | |
| IL100097A0 (en) | Pyridyl derivatives,their preparation and pharmaceutical compositions containing them | |
| IL93949A0 (en) | Thioformamide derivatives and pharmaceutical compositions containing them | |
| DE69330269D1 (de) | Benzopyran-derivate, deren herstellung sowie diese als aktive bestandteile enthaltende arzneimittel | |
| KR937000436A (ko) | 신규 아릴알카노일아민 유도체 및 이를 함유하는 의약 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |